SCHEMBL18230383

SCHEMBL18230383

CCCc1sc(N)nc1-c1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
GAA P10253 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HTT P42858 1/20 0.54
FBP1 P09467 3/20 0.50
TGFBR1 P36897 8/20 0.49
MAPT P10636 1/20 0.48
PIK3CD O00329 1/20 0.43
PIK3CA P42336 1/20 0.43
PI4KA P42356 1/20 0.43
PIK3CG P48736 1/20 0.43
PI4KB Q9UBF8 1/20 0.43
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31361560 0.88 MAPT (0.62) ALDH1A1GAASMN1; SMN2TGFBR1MAPT
SCHEMBL19783113 0.85 TGFBR1 (0.49) ALDH1A1GAASMN1; SMN2HTTFBP1
SCHEMBL14726501 0.78 ALDH1A1 (0.76) ALDH1A1GAASMN1; SMN2HTTFBP1
SCHEMBL11796387 0.76 TGFBR1 (0.56) SMN1; SMN2TGFBR1MAPTPIK3CDPIK3CA
SCHEMBL24358097 0.76 TGFBR1 (0.41) ALDH1A1GAASMN1; SMN2TGFBR1MAPT
Bromide SCHEMBL29078717 0.75 TGFBR1 (0.54) SMN1; SMN2TGFBR1MAPTPIK3CDPIK3CA
SCHEMBL13506384 0.74 KDM4E (0.50) ALDH1A1GAASMN1; SMN2HTTMAPT
SCHEMBL31361561 0.73 TGFBR1 (0.55) SMN1; SMN2HTTTGFBR1MAPTPIK3CD
SCHEMBL3737029 0.73 TGFBR1 (0.55) SMN1; SMN2HTTTGFBR1MAPTPIK3CD
SCHEMBL18230501 0.73 TGFBR1 (0.51) TGFBR1MAPTPIK3CDPIK3CAPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016183173-A1 ANTIPARASITIC COMPOUNDS Avista Pharma Solutions (US) 2016-11-17 WO disclosed
WO-2016183173-A1 ANTIPARASITIC COMPOUNDS Avista Pharma Solutions (US) 2016-11-17 WO disclosed